Theranostics 2018; 8(8):2242-2244. doi:10.7150/thno.25181


OVOL2 in metastasis prevention in NPC

Kyung-A Song, Anthony C. Faber

Philips Institute for Oral Health Research, VCU School of Dentistry and Massey Cancer Center, Richmond, VA 23298


Metastasis remains a critical - and largely elusive - target in the race to prevent cancer-related deaths. Such is true in nasopharyngeal carcinoma (NPC), where the presentation or development of metastatic disease is usually fatal. In this edition of Theranostics, Qi et al. demonstrate a critical role of the zinc-finger transcription factor, OVOL2, in suppressing metastasis and maintaining an epithelial phenotype. These data add to the depth of understanding of the metastatic program in NPC, and may eventually lead to a druggable target in late-stage NPC.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license ( See for full terms and conditions.
How to cite this article:
Song KA, Faber AC. OVOL2 in metastasis prevention in NPC. Theranostics 2018; 8(8):2242-2244. doi:10.7150/thno.25181. Available from